The Biden administration’s final rule prohibits the disclosure of protected health information to law enforcement when it comes to patients seeking abortions in other states.
Nearly 80% of Americans want stricter AI regulations. Where does the U.S. stand?
Former president Donald Trump said this week he did not support a federal abortion ban, and that abortion rights should be left to the states to decide instead.
‘We beat Big Pharma’: President Biden, Bernie Sanders tout drug pricing reform
President Joe Biden and Sen. Bernie Sanders teamed up to push more efforts on drug pricing reform, including lowering the out-of-pocket cost of inhalers.
What the Supreme Court’s mifepristone hearing could mean for pharma
Anti-abortion plaintiffs argued against the FDA’s expanded access to the abortion pill in a case that could have significant implications for the pharma industry.
5 healthcare takeaways from President Biden’s 2024 State of the Union address
President Biden emphasized more drug pricing reform and highlighted his administration’s commitment to reproductive rights in the State of the Union address.
How the CDC plans to improve public health messaging in a post-COVID world
Even as the COVID-19 pandemic recedes from memory, the CDC is still grappling with public distrust in the wake of its communications blunders. Here’s how the agency plans to rebuild trust.
PBM trade group pushes back on House bill targeting spread pricing
The House Committee on Oversight and Accountability recently voted to advance another PBM reform bill in Congress. Here’s how the PBM industry responded.
Bernie vs. Big Pharma: Senate hearing exposes rift over high drug prices
CEOs from Johnson & Johnson, Merck and Bristol Myers Squibb all testified at a Senate HELP committee hearing that questioned them about high drug prices. But many of the same arguments ensued with the chair Sen. Bernie Sanders, (I-VT).